Tesla, Teva, and the Danger of Debt
Aug 3, 2017 ·
19m 24s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Tesla shares rise on strong 2nd-quarter profits, but the company still needs cash. Bill Mann analyzes Tesla’s short-term future and why Elon Musk continues to set ambitious production targets. Teva...
show more
Tesla shares rise on strong 2nd-quarter profits, but the company still needs cash. Bill Mann analyzes Tesla’s short-term future and why Elon Musk continues to set ambitious production targets. Teva Pharmaceuticals sinks to a 13-year low on a bad 2nd-quarter report combined with slashing the dividend. Plus, Bill shares observations, both business and personal, from his recent trip to Africa. Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool
show less
Information
| Author | The Motley Fool |
| Organization | The Motley Fool |
| Website | - |
| Tags |
Copyright 2026 - Spreaker Inc. an iHeartMedia Company
Comments